Therapeutic Effectiveness of Galphimia glauca in Young People with Social Anxiety Disorder: A Pilot Study

Table 2

Effect produced by the administration of a standardized extract of G. glauca (experimental group) or sertraline (control group) in patients with a diagnosis of social anxiety, evaluated at two, four, six, eight and ten weeks, using the “Patient’s Global Impression Scale for Improvement” and the “Physician’s Global Impression Scale for Improvement”.

	Patient’s global impression scale for improvement			Physician’s global impression scale for improvement
Variable	G. glauca	Sertraline	p	G. glauca	Sertraline	p
	% (frequency)	% (frequency)		% (frequency)	% (frequency)
Two weeks
Much better	17.6 (3)	29.4 (5)		52.9 (9)	70.5(12)	0.46
Better	52.9 (9)	47.0 (8)	0.30	29.4 (5)	29.4 (5)
Without changes	29.4 (5)	23.5 (4)		17.6 (3)	0 (0)
Four weeks
Much better	50 (7)	60 (9)		78.6 (11)	93.3 (14)	0.44
Better	21.4 (3)	33.3 (5)	0.14	7.1 (1)	6.6 (1)
Without changes	28.5 (4)	6.6 (1)		14.2 (2)	0 (0)
Six weeks
Much better	71.4 (10)	66.6(10)		100 (14)	86.6 (13)	0.63
Better	28.5 (4)	33.3 (5)	0.62	0 (0)	13.3 (2)
Without changes	0 (0)	0 (0)		0 (0)	0 (0)
Eight weeks
Asymptomatic	7.1 (1)	0 (0)		7.1 (1)	0 (0)
Much better	78.5 (11)	80 (12)		92.8 (13)	86.6 (13)	0.51
Better	14.2 (2)	20 (3)	0.65	0 (0)	13.3 (2)
Ten weeks
Asymptomatic	14.2 (2)	13.3 (2)	0.18	14.2 (2)	6.6 (1)	0.18
Much better	85.7 (12)	86.6 (13)		85.7 (12)	93.3 (14)